| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |